NEW2026 · Text us +1 272-529-4722
Acyclovir is a highly effective, synthetic purine nucleoside analog with targeted inhibitory activity against the herpesvirus family, including Herpes Simplex Virus (HSV) types 1 and 2 and Varicella-Zoster Virus (VZV). Available in topical, oral, and intravenous forms, it remains a cornerstone treatment for managing various viral outbreaks, from common cold sores to life-threatening encephalitis. Its clinical utility stems from a unique three-step activation mechanism dependent on viral thymidin
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Form
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Acyclovir is a highly effective, synthetic purine nucleoside analog with targeted inhibitory activity against the herpesvirus family, including Herpes Simplex Virus (HSV) types 1 and 2 and Varicella-Zoster Virus (VZV). Available in topical, oral, and intravenous forms, it remains a cornerstone treatment for managing various viral outbreaks, from common cold sores to life-threatening encephalitis. Its clinical utility stems from a unique three-step activation mechanism dependent on viral thymidine kinase, which provides highly selective antiviral action with minimal toxicity to uninfected host cells. Acyclovir is one of the most widely used antivirals in clinical medicine and has well-established safety data across short-term and long-term use.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
A licensed provider reviews your screening answers, typically within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Acyclovir is a highly effective, synthetic purine nucleoside analog renowned for its targeted inhibitory activity against the herpesvirus family, including Herpes Simplex Virus (HSV) types 1 and 2 and Varicella-Zoster Virus (VZV). Available in topical, oral, and intravenous forms, acyclovir remains a cornerstone treatment for managing various viral outbreaks, from common cold sores to life-threatening encephalitis. Its clinical utility stems from its unique activation mechanism, which provides selective antiviral action.
Acyclovir, chemically known as 9-(2-hydroxyethoxymethyl)guanine, is a synthetic nucleoside analog that structurally resembles guanosine, one of the four building blocks of DNA. However, unlike natural nucleosides, acyclovir lacks the complete deoxyribose ring, which is crucial for its function as a selective chain terminator. This critical structural difference is the foundation of its impressive safety profile and highly targeted action against viral pathogens.
Acyclovir is indicated for the treatment and prevention of infections caused by HSV and VZV. Dosage and formulation depend critically on the specific viral infection and the patient’s immune status.
Herpes Simplex Virus (HSV-1 and HSV-2)
Genital Herpes (HSV-2):
Orolabial Herpes (Cold Sores, HSV-1):
Severe HSV Infections: High-dose IV acyclovir is essential for severe, life-threatening manifestations, including herpes simplex encephalitis (HSE), neonatal herpes, and severe mucocutaneous infections in immunocompromised patients. HSE requires prompt diagnosis and immediate IV treatment to minimize morbidity and mortality.
Varicella-Zoster Virus (VZV)
Administration & Dosage
Acyclovir tablets should be taken orally at evenly spaced intervals throughout the day — typically two to five times daily, depending on the indication and dose your provider has prescribed. Taking acyclovir with food is acceptable and may reduce the mild nausea some patients experience, though food does not significantly affect absorption. Staying well hydrated is particularly important during acyclovir therapy, as adequate fluid intake helps protect kidney function and supports drug clearance. Take acyclovir at the same time each day to maintain consistent drug levels, and complete the full prescribed course even if symptoms improve before it is finished.
The appropriate dose of acyclovir depends on the specific indication and severity, and your prescribing provider will tailor it accordingly. For cold sores in adults, common oral dosing is 400 mg three times daily or 200 mg five times daily for five days. For genital herpes outbreaks, typical doses range from 200 mg five times daily to 400 mg three times daily for five to ten days, depending on whether it is a first or recurrent episode. For shingles, 800 mg five times daily for seven to ten days is the standard adult regimen. Never self-adjust doses; your provider will specify the regimen appropriate for your clinical situation.
Acyclovir cream 5% is applied topically to cold sores on the lips and face five times daily for four days, ideally starting at the earliest sign of an outbreak — tingling, itching, or redness — before a blister fully forms. Apply a thin layer using a clean fingertip or cotton swab, covering the cold sore and the immediately surrounding skin. Wash your hands before and after application to avoid spreading the virus to other areas or to other people. Do not apply acyclovir cream inside the mouth, near the eyes, or to genital areas — the cream formulation is specifically for cold sores on the lips and face in immunocompetent patients.
The effectiveness of acyclovir relies entirely on viral enzymes, making it a highly selective drug. The process involves a unique three-step phosphorylation cascade.
Step 1: Viral Activation (The Key to Selectivity)
The initial, and rate-limiting, step is the phosphorylation of acyclovir to acyclovir monophosphate. This conversion is performed almost exclusively by the enzyme thymidine kinase (TK), which is encoded by the herpesvirus itself. Cells not infected by the herpesvirus produce little to no of this viral TK, which means acyclovir remains largely inactive and nontoxic to uninfected host cells. This high degree of viral selectivity minimizes adverse effects on the patient’s body compared to less selective broad-spectrum antivirals.
Step 2: Cellular Conversion
Once the drug is activated to its monophosphate form, cellular enzymes—specifically guanylate kinase and other kinases—further phosphorylate it, first converting it to acyclovir diphosphate and finally to the active antiviral metabolite, acyclovir triphosphate (Acy-TP).
Step 3: Viral DNA Chain Termination
Acyclovir triphosphate acts through two powerful mechanisms to halt viral replication:
Pharmacokinetics and the Critical Role of Renal Function
Acyclovir exhibits variable and incomplete oral bioavailability (approximately 10% to 20%), which limits the maximum concentration achievable in the bloodstream. Peak plasma concentrations are reached about 1.5 to 2 hours after dosing.
The drug is primarily eliminated unchanged by the kidneys, through a combination of glomerular filtration and tubular secretion. The elimination half-life is typically around 2.5 to 3.3 hours in adults with normal renal function. This renal clearance is the most significant clinical consideration.
Renal Function Adjustment (A Critical Safety Point)
Because acyclovir is heavily reliant on renal excretion, patients with impaired kidney function (creatinine clearance less than 50 mL/min) require a significant dose reduction and/or an extended dosing interval. Failure to adjust the dose in these populations can lead to systemic accumulation of acyclovir, increasing the risk of dose-related adverse events, particularly neurotoxicity and nephrotoxicity.
Genital Herpes (HSV-2)
Orolabial Herpes (Cold Sores, HSV-1)
Herpes Zoster (Shingles)
800 mg five times daily for 7 to 10 days, initiated as soon as possible after the rash appears, ideally within 72 hours.
Severe HSV Infections
High-dose IV acyclovir for herpes simplex encephalitis, neonatal herpes, and severe mucocutaneous infections in immunocompromised patients.
Administration Guidelines
Common Side Effects (Oral)
Serious Adverse Events and Monitoring
Viral Resistance
Acyclovir resistance is a growing clinical concern, predominantly observed in immunocompromised patients (e.g., those with advanced HIV infection or organ transplant recipients) who receive prolonged or repeated courses of the drug. Resistance is generally due to mutations in the viral TK gene, leading to:
When acyclovir resistance is suspected, particularly in chronic, non-healing lesions, alternative antiviral therapies, such as foscarnet or cidofovir, are typically employed, as these drugs do not require activation by viral TK.
Contraindications
Acyclovir Contraindications
Acyclovir cream and tablets can be used together in certain clinical situations — the two formulations work through the same antiviral mechanism but address different aspects of the infection. Topical cream provides direct antiviral activity at the skin surface of a cold sore, while oral tablets produce systemic drug levels that address viral replication more broadly. For severe or frequently recurring outbreaks, some providers prescribe both simultaneously, though the incremental benefit of adding cream to oral therapy is modest for most patients. Your provider will determine whether combination use is appropriate for your specific situation.
Acyclovir can be taken daily on a long-term suppressive basis for patients with frequent recurrent genital herpes outbreaks. Suppressive therapy — typically 400 mg twice daily — significantly reduces recurrence frequency and can also reduce the risk of transmitting herpes to a partner. Daily suppressive acyclovir is safe for extended use in most patients, with studies demonstrating tolerability over periods of years. Your provider will assess whether your recurrence frequency and clinical situation make daily suppressive therapy appropriate, and will periodically reassess whether continued suppression remains necessary.
For episodic treatment of herpes outbreaks, acyclovir courses typically last five to ten days. For suppressive therapy in patients with frequent recurrences, acyclovir may be taken continuously for months to years — long-term safety data support extended use under medical supervision. Periodic reassessment is recommended; some providers suggest a trial off suppressive therapy after one year to evaluate whether the recurrence rate has decreased enough that continuous treatment remains warranted. The decision to continue, pause, or stop long-term acyclovir should always be made in consultation with your provider.
Uses & Mechanism of Action
Acyclovir is an antiviral medication used to treat infections caused by herpes viruses. FDA-approved indications for oral acyclovir include genital herpes — both initial episodes and recurrent outbreaks — herpes zoster (shingles), varicella (chickenpox), herpes simplex encephalitis, and neonatal herpes. Acyclovir cream is specifically indicated for recurrent herpes labialis (cold sores) on the lips and face in immunocompetent adults and adolescents. Acyclovir ointment is used for the initial treatment of genital herpes and mucocutaneous herpes simplex infections in immunocompromised patients. Off-label uses include prophylaxis against herpes simplex virus in immunocompromised patients and treatment of Epstein-Barr virus infections in some clinical contexts.
Acyclovir is a synthetic nucleoside analog antiviral — the first antiviral drug approved specifically for herpes virus infections and one of the most widely used antivirals in clinical medicine since its development in the 1970s. It is available as oral tablets and capsules, topical cream and ointment, and intravenous solution for hospital use. Acyclovir is not an antibiotic and has no antibacterial activity — it works exclusively against certain viruses and cannot treat bacterial infections. The brand-name Zovirax contains the same compound, and generic acyclovir is widely available and bioequivalent to the branded product.
Acyclovir works by mimicking a naturally occurring nucleoside — a building block of viral DNA — and exploiting a key difference between virus-infected cells and normal cells. Inside cells infected with the herpes virus, acyclovir is selectively activated by a viral enzyme called thymidine kinase into its active phosphorylated form. This step occurs far more efficiently in infected cells than in healthy ones. This activated form then inhibits the viral DNA polymerase. It is incorporated into the viral DNA chain, causing chain termination, halting viral DNA replication, and preventing the virus from reproducing. Because activation depends primarily on the viral enzyme, acyclovir has high selectivity for infected cells and relatively low toxicity to normal tissue.
Side Effects & Safety
The most commonly reported side effects of oral acyclovir include nausea, vomiting, diarrhea, headache, and malaise — effects that are generally mild and tend to improve with continued use. Taking acyclovir with food and maintaining good hydration can reduce gastrointestinal side effects. Fatigue is a recognized but uncommon effect of oral acyclovir. Topical acyclovir cream may cause mild local reactions at the site of application, including stinging, burning, and itching, which are generally transient. More serious adverse effects — including nephrotoxicity and neurological effects — are more associated with high-dose intravenous acyclovir in hospital settings than with standard oral or topical use.
Acyclovir is an antiviral medication and lacks the antibacterial properties that underlie antibiotic-associated yeast infections. Unlike broad-spectrum antibiotics, acyclovir does not disrupt the normal bacterial flora that keeps Candida overgrowth in check, and yeast infection is not a recognized pharmacological side effect of acyclovir. If you develop a yeast infection while taking acyclovir, another cause — including recent antibiotic use, immune status, or other individual factors — is more likely responsible. Discuss any concurrent symptoms with your provider rather than attributing them to acyclovir.
Diarrhea is a recognized gastrointestinal side effect of oral acyclovir, though it is generally mild and resolves without requiring discontinuation of treatment. Taking acyclovir with food rather than on an empty stomach may help reduce this effect. If diarrhea is severe, persistent, or accompanied by abdominal cramps and fever, contact your provider. Severe diarrhea during any antiviral therapy warrants evaluation to rule out other causes, though Clostridioides difficile infection is uncommon with acyclovir specifically.
Interactions & Contraindications
Acyclovir is one of the more extensively studied antivirals in pregnancy and is generally considered appropriate when clinically indicated. The Acyclovir in Pregnancy Registry, which collected data over many years, did not identify a significant increase in congenital disabilities associated with first-trimester exposure, providing reassurance about its safety profile. Acyclovir is commonly used for genital herpes suppression in the third trimester to reduce the risk of transmission to the newborn during delivery — a clinically important use where the benefit clearly outweighs theoretical risk. All use during pregnancy should be under the direction of the prescribing provider and OB-GYN.
Acyclovir is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. It requires significant dose adjustment in patients with renal impairment, as the kidneys primarily excrete acyclovir — reduced clearance leads to drug accumulation. It increases the risk of nephrotoxicity and neurological side effects. Patients with severe renal impairment or those on dialysis require specialist guidance on appropriate dosing. Older adults are at increased risk of acyclovir-related neurological effects and renal toxicity and require careful dose adjustment based on estimated kidney function.
Acyclovir has relatively few clinically significant drug interactions compared to many antivirals. Probenecid and cimetidine can reduce renal tubular secretion of acyclovir, raising blood levels — this effect may be clinically relevant at higher doses. Other nephrotoxic drugs — including NSAIDs, aminoglycosides, and intravenous contrast agents — can compound acyclovir's renal toxicity risk, particularly in patients with pre-existing kidney compromise or those receiving high doses. Mycophenolate mofetil levels may be modestly affected by concurrent acyclovir use in transplant patients. Inform your prescriber and pharmacist of all current medications before starting acyclovir.
Generic & Alternatives
The generic name for Zovirax is acyclovir, and generic acyclovir tablets, capsules, cream, and ointment are widely available in the United States at substantially lower cost than the original branded product. Generic acyclovir is considered bioequivalent to Zovirax by the FDA and provides equivalent antiviral activity. Generic acyclovir cream 5% is the topical equivalent of Zovirax Cream. Your pharmacist can confirm current generic availability and pricing across formulations.
Acyclovir cream 5% is a prescription-only medication in the United States and is not available over the counter despite being a topical formulation. This distinguishes it from docosanol cream (Abreva), an OTC cold sore treatment, though docosanol acts through a different mechanism and is generally considered less potent than acyclovir. Oral acyclovir tablets are also prescription-only in all available strengths. A consultation with a healthcare provider is the appropriate first step to obtain a prescription for either formulation.
Acyclovir has a plasma half-life of approximately 2 to 3 hours in adults with normal kidney function, meaning it is largely cleared from the bloodstream within 10 to 15 hours after a dose, which is why multiple daily doses are required to maintain consistent antiviral drug levels. In patients with renal impairment, the half-life extends significantly as clearance slows, increasing the risk of drug accumulation and requiring dose adjustment. Following a complete course of oral acyclovir, the drug is generally eliminated within one to two days of the last dose. Acyclovir applied as a cream produces minimal systemic absorption and does not contribute meaningfully to systemic drug levels.
The most commonly used alternative to acyclovir is valacyclovir (Valtrex) — acyclovir's prodrug — which is generally preferred over oral acyclovir for most herpes indications due to its higher bioavailability and more convenient dosing. Famciclovir (Famvir) is another alternative antiviral in the same class with a similar mechanism and comparable efficacy for genital herpes and shingles, and is used when valacyclovir is not tolerated. For cold sores specifically, OTC docosanol (Abreva) cream is an alternative for patients who cannot obtain a prescription, though acyclovir cream is considered more effective. For shingles, valacyclovir and famciclovir are both preferred over acyclovir due to more convenient dosing and comparable or superior clinical outcomes. {"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"How should you take acyclovir tablets?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir tablets should be taken orally at evenly spaced intervals throughout the day — typically two to five times daily, depending on the indication and dose your provider has prescribed. Taking acyclovir with food is acceptable and may reduce the mild nausea some patients experience, though food does not significantly affect absorption. Staying well hydrated is particularly important during acyclovir therapy, as adequate fluid intake helps protect kidney function and supports drug clearance. Take acyclovir at the same time each day to maintain consistent drug levels, and complete the full prescribed course even if symptoms improve before it is finished."}},{"@type":"Question","name":"How much acyclovir should you take for a cold sore or herpes outbreak?","acceptedAnswer":{"@type":"Answer","text":"The appropriate dose of acyclovir depends on the specific indication and severity, and your prescribing provider will tailor it accordingly. For cold sores in adults, common oral dosing is 400 mg three times daily or 200 mg five times daily for five days. For genital herpes outbreaks, typical doses range from 200 mg five times daily to 400 mg three times daily for five to ten days, depending on whether it is a first or recurrent episode. For shingles, 800 mg five times daily for seven to ten days is the standard adult regimen. Never self-adjust doses; your provider will specify the regimen appropriate for your clinical situation."}},{"@type":"Question","name":"How should you apply acyclovir cream?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir cream 5% is applied topically to cold sores on the lips and face five times daily for four days, ideally starting at the earliest sign of an outbreak — tingling, itching, or redness — before a blister fully forms. Apply a thin layer using a clean fingertip or cotton swab, covering the cold sore and the immediately surrounding skin. Wash your hands before and after application to avoid spreading the virus to other areas or to other people. Do not apply acyclovir cream inside the mouth, near the eyes, or to genital areas — the cream formulation is specifically for cold sores on the lips and face in immunocompetent patients."}},{"@type":"Question","name":"Can you use acyclovir cream and tablets together?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir cream and tablets can be used together in certain clinical situations — the two formulations work through the same antiviral mechanism but address different aspects of the infection. Topical cream provides direct antiviral activity at the skin surface of a cold sore, while oral tablets produce systemic drug levels that address viral replication more broadly. For severe or frequently recurring outbreaks, some providers prescribe both simultaneously, though the incremental benefit of adding cream to oral therapy is modest for most patients. Your provider will determine whether combination use is appropriate for your specific situation."}},{"@type":"Question","name":"Can you take acyclovir daily for suppression?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir can be taken daily on a long-term suppressive basis for patients with frequent recurrent genital herpes outbreaks. Suppressive therapy — typically 400 mg twice daily — significantly reduces recurrence frequency and can also reduce the risk of transmitting herpes to a partner. Daily suppressive acyclovir is safe for extended use in most patients, with studies demonstrating tolerability over periods of years. Your provider will assess whether your recurrence frequency and clinical situation make daily suppressive therapy appropriate, and will periodically reassess whether continued suppression remains necessary."}},{"@type":"Question","name":"How long can you take acyclovir for herpes?","acceptedAnswer":{"@type":"Answer","text":"For episodic treatment of herpes outbreaks, acyclovir courses typically last five to ten days. For suppressive therapy in patients with frequent recurrences, acyclovir may be taken continuously for months to years — long-term safety data support extended use under medical supervision. Periodic reassessment is recommended; some providers suggest a trial off suppressive therapy after one year to evaluate whether the recurrence rate has decreased enough that continuous treatment remains warranted. The decision to continue, pause, or stop long-term acyclovir should always be made in consultation with your provider."}},{"@type":"Question","name":"What is acyclovir used for?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir is an antiviral medication used to treat infections caused by herpes viruses. FDA-approved indications for oral acyclovir include genital herpes — both initial episodes and recurrent outbreaks — herpes zoster (shingles), varicella (chickenpox), herpes simplex encephalitis, and neonatal herpes. Acyclovir cream is specifically indicated for recurrent herpes labialis (cold sores) on the lips and face in immunocompetent adults and adolescents. Acyclovir ointment is used for the initial treatment of genital herpes and mucocutaneous herpes simplex infections in immunocompromised patients. Off-label uses include prophylaxis against herpes simplex virus in immunocompromised patients and treatment of Epstein-Barr virus infections in some clinical contexts."}},{"@type":"Question","name":"What is acyclovir?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir is a synthetic nucleoside analog antiviral — the first antiviral drug approved specifically for herpes virus infections and one of the most widely used antivirals in clinical medicine since its development in the 1970s. It is available as oral tablets and capsules, topical cream and ointment, and intravenous solution for hospital use. Acyclovir is not an antibiotic and has no antibacterial activity — it works exclusively against certain viruses and cannot treat bacterial infections. The brand-name Zovirax contains the same compound, and generic acyclovir is widely available and bioequivalent to the branded product."}},{"@type":"Question","name":"How does acyclovir work?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir works by mimicking a naturally occurring nucleoside — a building block of viral DNA — and exploiting a key difference between virus-infected cells and normal cells. Inside cells infected with the herpes virus, acyclovir is selectively activated by a viral enzyme called thymidine kinase into its active phosphorylated form. This step occurs far more efficiently in infected cells than in healthy ones. This activated form then inhibits the viral DNA polymerase. It is incorporated into the viral DNA chain, causing chain termination, halting viral DNA replication, and preventing the virus from reproducing. Because activation depends primarily on the viral enzyme, acyclovir has high selectivity for infected cells and relatively low toxicity to normal tissue."}},{"@type":"Question","name":"What is the difference between acyclovir and valacyclovir?","acceptedAnswer":{"@type":"Answer","text":"Valacyclovir is a prodrug of acyclovir — it is converted into acyclovir in the body after oral absorption and works through the same antiviral mechanism. The key practical difference is bioavailability: oral acyclovir is poorly absorbed from the gastrointestinal tract, with only about 15-30% of the dose reaching the bloodstream. Valacyclovir is absorbed far more efficiently and rapidly converted to acyclovir, resulting in blood levels three to five times higher than those achieved with equivalent oral acyclovir doses. This allows valacyclovir to be dosed less frequently — typically twice or three times daily rather than five times daily — while achieving superior systemic drug levels. For most herpes indications, valacyclovir is now preferred over oral acyclovir due to its more convenient dosing and higher bioavailability."}},{"@type":"Question","name":"Does acyclovir work?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir has well-established antiviral efficacy against herpes simplex viruses types 1 and 2, varicella-zoster virus, and Epstein-Barr virus, supported by decades of clinical evidence. For genital herpes, acyclovir reduces the duration and severity of first episodes and recurrent outbreaks when started promptly, and suppressive therapy significantly reduces the frequency of recurrences. For shingles, it reduces the duration of the rash and associated pain when started within 72 hours of rash onset. Acyclovir cream modestly reduces the duration of cold sore episodes when applied at the earliest sign of an outbreak. Acyclovir does not eliminate latent herpesvirus from nerve ganglia — the virus persists in a dormant state and can reactivate, which is why recurrences can occur even after successful treatment."}},{"@type":"Question","name":"What are the side effects of acyclovir?","acceptedAnswer":{"@type":"Answer","text":"The most commonly reported side effects of oral acyclovir include nausea, vomiting, diarrhea, headache, and malaise — effects that are generally mild and tend to improve with continued use. Taking acyclovir with food and maintaining good hydration can reduce gastrointestinal side effects. Fatigue is a recognized but uncommon effect of oral acyclovir. Topical acyclovir cream may cause mild local reactions at the site of application, including stinging, burning, and itching, which are generally transient. More serious adverse effects — including nephrotoxicity and neurological effects — are more associated with high-dose intravenous acyclovir in hospital settings than with standard oral or topical use."}},{"@type":"Question","name":"Does acyclovir cause yeast infections?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir is an antiviral medication and lacks the antibacterial properties that underlie antibiotic-associated yeast infections. Unlike broad-spectrum antibiotics, acyclovir does not disrupt the normal bacterial flora that keeps Candida overgrowth in check, and yeast infection is not a recognized pharmacological side effect of acyclovir. If you develop a yeast infection while taking acyclovir, another cause — including recent antibiotic use, immune status, or other individual factors — is more likely responsible. Discuss any concurrent symptoms with your provider rather than attributing them to acyclovir."}},{"@type":"Question","name":"Does acyclovir cause diarrhea?","acceptedAnswer":{"@type":"Answer","text":"Diarrhea is a recognized gastrointestinal side effect of oral acyclovir, though it is generally mild and resolves without requiring discontinuation of treatment. Taking acyclovir with food rather than on an empty stomach may help reduce this effect. If diarrhea is severe, persistent, or accompanied by abdominal cramps and fever, contact your provider. Severe diarrhea during any antiviral therapy warrants evaluation to rule out other causes, though Clostridioides difficile infection is uncommon with acyclovir specifically."}},{"@type":"Question","name":"Does acyclovir expire?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir tablets, capsules, and cream carry manufacturer-specified expiration dates; using the product beyond those dates is not recommended. After expiration, the stability of the active compound cannot be guaranteed — the drug may have degraded, reducing its antiviral effectiveness. Acyclovir cream should be stored at room temperature away from heat and direct light. Do not use a tube that has changed color, developed an unusual odor, or appears otherwise altered. Dispose of expired antiviral medications through a pharmacy take-back program rather than flushing or placing them in household trash."}},{"@type":"Question","name":"Can you drink alcohol while taking acyclovir?","acceptedAnswer":{"@type":"Answer","text":"There is no direct pharmacological interaction between acyclovir and alcohol, and no absolute contraindication against moderate alcohol consumption during therapy. However, alcohol can contribute to dehydration — a meaningful concern during acyclovir treatment, as adequate hydration is important for protecting kidney function and supporting drug clearance, particularly at higher doses. Alcohol may also compound the fatigue and malaise that some patients experience during herpes outbreaks and antiviral treatment. Staying well hydrated throughout the course of acyclovir therapy is advisable regardless of alcohol consumption."}},{"@type":"Question","name":"Is acyclovir safe during pregnancy?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir is one of the more extensively studied antivirals in pregnancy and is generally considered appropriate when clinically indicated. The Acyclovir in Pregnancy Registry, which collected data over many years, did not identify a significant increase in congenital disabilities associated with first-trimester exposure, providing reassurance about its safety profile. Acyclovir is commonly used for genital herpes suppression in the third trimester to reduce the risk of transmission to the newborn during delivery — a clinically important use where the benefit clearly outweighs theoretical risk. All use during pregnancy should be under the direction of the prescribing provider and OB-GYN."}},{"@type":"Question","name":"Who should not take acyclovir?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir is contraindicated in patients with known hypersensitivity to acyclovir, valacyclovir, or any component of the formulation. It requires significant dose adjustment in patients with renal impairment, as the kidneys primarily excrete acyclovir — reduced clearance leads to drug accumulation. It increases the risk of nephrotoxicity and neurological side effects. Patients with severe renal impairment or those on dialysis require specialist guidance on appropriate dosing. Older adults are at increased risk of acyclovir-related neurological effects and renal toxicity and require careful dose adjustment based on estimated kidney function."}},{"@type":"Question","name":"What drugs interact with acyclovir?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir has relatively few clinically significant drug interactions compared to many antivirals. Probenecid and cimetidine can reduce renal tubular secretion of acyclovir, raising blood levels — this effect may be clinically relevant at higher doses. Other nephrotoxic drugs — including NSAIDs, aminoglycosides, and intravenous contrast agents — can compound acyclovir's renal toxicity risk, particularly in patients with pre-existing kidney compromise or those receiving high doses. Mycophenolate mofetil levels may be modestly affected by concurrent acyclovir use in transplant patients. Inform your prescriber and pharmacist of all current medications before starting acyclovir."}},{"@type":"Question","name":"Can acyclovir be used in children?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir has well-established pediatric uses and is FDA-approved for the treatment of chickenpox in children aged two years and older and for herpes simplex infections, including neonatal herpes. Intravenous acyclovir is the standard of care for neonatal herpes and herpes simplex encephalitis in newborns and children — conditions requiring hospital-level treatment. Dosing in children is weight-based and calculated by the treating provider. Acyclovir cream is approved for cold sores in adolescents aged 12 and older. For chickenpox in otherwise healthy children, the pediatrician makes the clinical decision to treat with acyclovir or allow the illness to resolve based on the child's age, illness severity, and immune status."}},{"@type":"Question","name":"What is the generic name for Zovirax?","acceptedAnswer":{"@type":"Answer","text":"The generic name for Zovirax is acyclovir, and generic acyclovir tablets, capsules, cream, and ointment are widely available in the United States at substantially lower cost than the original branded product. Generic acyclovir is considered bioequivalent to Zovirax by the FDA and provides equivalent antiviral activity. Generic acyclovir cream 5% is the topical equivalent of Zovirax Cream. Your pharmacist can confirm current generic availability and pricing across formulations."}},{"@type":"Question","name":"Is acyclovir cream available over the counter?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir cream 5% is a prescription-only medication in the United States and is not available over the counter despite being a topical formulation. This distinguishes it from docosanol cream (Abreva), an OTC cold sore treatment, though docosanol acts through a different mechanism and is generally considered less potent than acyclovir. Oral acyclovir tablets are also prescription-only in all available strengths. A consultation with a healthcare provider is the appropriate first step to obtain a prescription for either formulation."}},{"@type":"Question","name":"How long does acyclovir stay in your system?","acceptedAnswer":{"@type":"Answer","text":"Acyclovir has a plasma half-life of approximately 2 to 3 hours in adults with normal kidney function, meaning it is largely cleared from the bloodstream within 10 to 15 hours after a dose, which is why multiple daily doses are required to maintain consistent antiviral drug levels. In patients with renal impairment, the half-life extends significantly as clearance slows, increasing the risk of drug accumulation and requiring dose adjustment. Following a complete course of oral acyclovir, the drug is generally eliminated within one to two days of the last dose. Acyclovir applied as a cream produces minimal systemic absorption and does not contribute meaningfully to systemic drug levels."}},{"@type":"Question","name":"Are there alternatives to acyclovir for herpes treatment?","acceptedAnswer":{"@type":"Answer","text":"The most commonly used alternative to acyclovir is valacyclovir (Valtrex) — acyclovir's prodrug — which is generally preferred over oral acyclovir for most herpes indications due to its higher bioavailability and more convenient dosing. Famciclovir (Famvir) is another alternative antiviral in the same class with a similar mechanism and comparable efficacy for genital herpes and shingles, and is used when valacyclovir is not tolerated. For cold sores specifically, OTC docosanol (Abreva) cream is an alternative for patients who cannot obtain a prescription, though acyclovir cream is considered more effective. For shingles, valacyclovir and famciclovir are both preferred over acyclovir due to more convenient dosing and comparable or superior clinical outcomes."}}]}
Valacyclovir is a prodrug of acyclovir — it is converted into acyclovir in the body after oral absorption and works through the same antiviral mechanism. The key practical difference is bioavailability: oral acyclovir is poorly absorbed from the gastrointestinal tract, with only about 15-30% of the dose reaching the bloodstream. Valacyclovir is absorbed far more efficiently and rapidly converted to acyclovir, resulting in blood levels three to five times higher than those achieved with equivalent oral acyclovir doses. This allows valacyclovir to be dosed less frequently — typically twice or three times daily rather than five times daily — while achieving superior systemic drug levels. For most herpes indications, valacyclovir is now preferred over oral acyclovir due to its more convenient dosing and higher bioavailability.
Acyclovir has well-established antiviral efficacy against herpes simplex viruses types 1 and 2, varicella-zoster virus, and Epstein-Barr virus, supported by decades of clinical evidence. For genital herpes, acyclovir reduces the duration and severity of first episodes and recurrent outbreaks when started promptly, and suppressive therapy significantly reduces the frequency of recurrences. For shingles, it reduces the duration of the rash and associated pain when started within 72 hours of rash onset. Acyclovir cream modestly reduces the duration of cold sore episodes when applied at the earliest sign of an outbreak. Acyclovir does not eliminate latent herpesvirus from nerve ganglia — the virus persists in a dormant state and can reactivate, which is why recurrences can occur even after successful treatment.
Acyclovir tablets, capsules, and cream carry manufacturer-specified expiration dates; using the product beyond those dates is not recommended. After expiration, the stability of the active compound cannot be guaranteed — the drug may have degraded, reducing its antiviral effectiveness. Acyclovir cream should be stored at room temperature away from heat and direct light. Do not use a tube that has changed color, developed an unusual odor, or appears otherwise altered. Dispose of expired antiviral medications through a pharmacy take-back program rather than flushing or placing them in household trash.
There is no direct pharmacological interaction between acyclovir and alcohol, and no absolute contraindication against moderate alcohol consumption during therapy. However, alcohol can contribute to dehydration — a meaningful concern during acyclovir treatment, as adequate hydration is important for protecting kidney function and supporting drug clearance, particularly at higher doses. Alcohol may also compound the fatigue and malaise that some patients experience during herpes outbreaks and antiviral treatment. Staying well hydrated throughout the course of acyclovir therapy is advisable regardless of alcohol consumption.
Acyclovir has well-established pediatric uses and is FDA-approved for the treatment of chickenpox in children aged two years and older and for herpes simplex infections, including neonatal herpes. Intravenous acyclovir is the standard of care for neonatal herpes and herpes simplex encephalitis in newborns and children — conditions requiring hospital-level treatment. Dosing in children is weight-based and calculated by the treating provider. Acyclovir cream is approved for cold sores in adolescents aged 12 and older. For chickenpox in otherwise healthy children, the pediatrician makes the clinical decision to treat with acyclovir or allow the illness to resolve based on the child's age, illness severity, and immune status.